Green Cross Medical Science Corporation (KOSDAQ:142280)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,065.00
-10.00 (-0.25%)
At close: Dec 5, 2025
21.52%
Market Cap88.60B
Revenue (ttm)111.12B
Net Income (ttm)5.66B
Shares Out21.74M
EPS (ttm)150.83
PE Ratio27.02
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume55,726
Average Volume86,809
Open4,095.00
Previous Close4,075.00
Day's Range4,010.00 - 4,095.00
52-Week Range3,090.00 - 5,150.00
Beta0.53
RSI47.93
Earnings DateNov 14, 2025

About KOSDAQ:142280

Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin-Si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1972
Employees 122
Stock Exchange KOSDAQ
Ticker Symbol 142280
Full Company Profile

Financial Performance

In 2024, KOSDAQ:142280's revenue was 103.85 billion, an increase of 10.47% compared to the previous year's 94.01 billion. Earnings were 3.58 billion, an increase of 99.25%.

Financial Statements

News

There is no news available yet.